Enveric Biosciences's total assets for Q2 2026 were $8.94M, an increase of 61.99% from the previous quarter. DE:SLZ0 total liabilities were $861.48K for the fiscal quarter, a 87.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.